Table 1.
Demographic characteristics
| Tocilizumab | Dexamethasone | Statistical analysis | |
|---|---|---|---|
| Number of patients | 30 | 30 | NS |
| Sex | Male: 18 | Male: 16 | NS |
| Female: 12 | Female: 14 | ||
| Age mean range (range), years | 67 ± 6.5 (52–80) | 68 ± 5.5 (51–82) | NS |
| Symptom duration, mean (range), months | 3.0 (1–24) | 2.7 (1–24) | NS |
| Use of NSAIDs | 30 | 30 | NS |
| Pain score before infiltration | |||
| Leg pain | |||
| Visual analog scale (VAS) | 6.9 ± 2.1 | 6.5 ± 2.2 | NS |
| Leg numbness | |||
| Visual analog scale (VAS) | 5.9 ± 1.4 | 6.0 ± 1.7 | NS |
| Low back pain | |||
| Visual analog scale (VAS) | 4.0 ± 0.7 | 3.7 ± 0.9 | NS |
| Oswestry Disability Index (ODI) | 34 ± 7.2 | 41 ± 7.8 | NS |